However, the literature does not yet provide a fully resolved primary molecular target, a unified causal mechanism, or sufficient controlled human evidence to support conclusions about therapeutic use
Lean C57BL/6J mice and genetically obese (ob/ob) mice, all 12 weeks old, were divided into three treatment groups including: saline control, AOD9604 at a dose of 250 g/kg/day, and hGH at a dose of 1 mg/kg/day, with each group consisting of six mice
Patients should be advised that NHS-funded treatment duration is typically limited to a maximum of 2 years, as per NICE guidance, and that discontinuation often results in weight regain
The CAS number for BPC-157 is 137525-51-0, which uniquely identifies the compound for research and regulatory reference
S2) or phylogenetic diversity as measured by Faiths formula applied to the whole phylogenetic tree (Supplementary Fig
The once-weekly dosing and gradual dose escalation protocol may help minimise side effects